DanielHFrenningMD
Oncology • Robbinsdale, MNBreast Cancer, Gynecologic Cancer, Hematologic Oncology
Medical Oncologist, North Memorial Health Cancer Center, North Memorial Health, Robbinsdale, Minnesota
Dr. Frenning is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
North Memorial Health Cancer Center
3435 W Broadway Ave
Robbinsdale, MN 55422Phone+1 763-581-2806
Education & Training
University of MinnesotaFellowship, Hematology and Medical Oncology, 1976 - 1977- University of MinnesotaInternship, Internal Medicine, 1971 - 1972
- University of Minnesota Medical SchoolClass of 1970
Certifications & Licensure
MN State Medical License 1972 - 2023- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Member Alpha Omega Alpha Honor Society, 1970-2015
Publications & Presentations
PubMed
- 47 citationsCoronary artery disease after treatment with bleomycin and vinblastine.Nicholas J. Vogelzang, Daniel H. Frenning, B. J. Kennedy
Cancer Treatment Reports. 1980-10-01 - 173 citationsEstrogen Receptors and Responses to Chemotherapy and Hormonal Therapy in Advanced Breast CancerDavid T. Kiang, Daniel H. Frenning, Anne Goldman, Virginia F. Ascensao, B. J. Kennedy
The New England Journal of Medicine. 1978-12-14 - 2 citationsPhase II study of carboplatin and edatrexate (10-EdAM) with leucovorin rescue for patients with recurrent squamous cell carcinoma of the head and neck.Martin H. Huber, Isaiah W. Dimery, Steven E. Benner, Scott M. Lippman, Mihran Shirinian
Investigational New Drugs. 1994-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
